| PIE | 1) Post-Infectious Encephalomyelitis 2) Pulmonary Interstitial Emphysema;... |
|---|---|
| CFU-EOS, | CFUEOS colony-forming unit, eosinophil |
| ECP | ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat... |
| EDF | eosinophil differentiation factor; erythroid differentiation factor; extradural fluid |
| EDN | electrodesiccation; eosinophil-derived neurotoxin |
| EO | Eosinophil |
|---|---|
| ECP | Eosinophil Cationic Protein |
| ECA | Eosinophil chemotactic activity |
| ECF | Eosinophil chemotactic factor |
| EDN | Eosinophil derived neurotoxin |
| pair production | <physics> The simultaneous production of an electron and a positron by an interaction of a photon or a fast charged particle with the electronic field of a nucleus or other particle. (16 Dec 1997) |
|---|---|
| primary production | Production of organic substances by photosynthesis, the quantity of material so produced per unit time. (09 Oct 1997) |
| production | The act or process of producing, bringing forth or making. (18 Nov 1997) |
| speech production measurement | Measurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody. (12 Dec 1998) |
| steroid production rate | The total quantity of a given steroid formed in the body, usually expressed as milligrams per day; represents the sum of the glandular secretion of the steroid and extraglandular formation of it from various steroid precursors. (05 Mar 2000) |
| implantation theory of the production of endometriosis | That, at the time of menstruation, cells of the uterine mucosa pass through the fallopian tubes and escape into the pelvic cavity where they implant themselves on the peritoneum. (05 Mar 2000) |
| orphan drug production | Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others. (12 Dec 1998) |
| absolute eosinophil count | <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre). (27 Sep 1997) |
| chemotactic factors, eosinophil | Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ecf-a, released mainly by mast cells. (12 Dec 1998) |
| eosinophil | Polymorphonuclear leucocyte (granulocyte) of the myeloid series, of which the granules stain red with eosin. Phagocytic, particularly associated with helminth infections and with hypersensitivity. (18 Nov 1997) |
| eosinophil adenoma | <endocrinology, oncology, tumour> A benign tumour, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumours may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhoea. (25 Jun 1999) |
| eosinophil cationic protein | <protein> Arginine rich protein (21 kD) in granules of eosinophils, that damages schistosomula in vitro. Not the same as the MBP (major basic protein) of the granules. (18 Nov 1997) |
| eosinophil chemotactic factor of anaphylaxis | A peptide (MW 500 to 600) that is chemotactic for eosinophilic leukocytes and is released from disrupted mast cells. (05 Mar 2000) |
| eosinophil chemotactic peptide | <protein> Tetrapeptides (of which two are identified: VGSE and AGSE) released by mast cells and that are said to both attract and activate eosinophils. (18 Nov 1997) |
| eosinophil count | A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement, also called the absolute eosinophil count, is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre). (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|